Abstract
The use of biological therapy is now common practice in the treatment of immune-mediated inflammatory diseases (IMID). Currently, there are no guidelines related to the management of cytomegalovirus (CMV) infections or reactivation during therapy with biological agents. Furthermore, there is a lack of guidance on the management of asymptomatic patients with persistent positive immunoglobulin (Ig)M anti-CMV after an extended period and who have to undergo therapy with biological agents. We report the case of a patient in this situation for whom treatment with biological drugs for psoriasis was indicated. A good clinical response was obtained with secukinumab and maintained during 6 months of follow-up. No infectious disease or reactivation of CMV infection occurred. We suggest some possible guidelines for the management of such cases.
Acknowledgments
We thank Ray Hill, an independent medical writer, who provided English-language editing and journal styling prior to submission on behalf of Health Publishing & Services Srl. This unconditional support was funded by Novartis Farma SpA. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Ethics Statement
No institutional approval was required to publish the case details.
Patient Consent for Publication Statement
The patient provided written informed consent to the publication of his case details and images.
Disclosure
The authors declare no conflicts of interest in this work.